Represented GlaxoSmithKline between 2014 and 2019 in respect of the SFO’s investigation into GSK Plc, on suspicion of offences of bribery and corruption.
© 2022 | 6KBW | Website by Infoserve
Represented GlaxoSmithKline between 2014 and 2019 in respect of the SFO’s investigation into GSK Plc, on suspicion of offences of bribery and corruption.